Experiment 546293
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | SMIT,BJ: ALBRECHT,CF: LIEBENBERG,RW: KRUGER,PB: FREESTONE,M: GOUWS,L: THERON,E: BOUIC PJD: ETSEBETH,S: VAN JAARSVELD,PP:. (1995). A PHASE I TRIAL OF HYPOXOSIDE AS AN ORAL PRODRUG FOR CANCER THERAPY - ABSENCE OF TOXICITY.. 85(9) |
| Amount utilized | |
| Compound isolated | |
| Disease | 24 PATIENTS WITH LUNG CANCER WERE ENROLLED IN PHASE I STUDY OF EFFICACY OF COMPOUND IN TREATING THIS DISEASE. 5 EXHIBITED PROLONGED SURVIVAL NO HEMATOLOGIC TOXICITY NOTED. |
| Dose amount | 3.2 GM |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | PERSON |
| Dose expression | DOSE |